Immuno-metabolism axis of mood disorders: towards nutrition interventions

I am a researcher at Unit of Psychiatry and Clinical Psychobiology, IRCCS Ospedale San Raffaele in Italy. My main research interest and ongoing granted projects are focused on the identification of reliable biomarkers, new therapeutic targets, or predictors of clinical outcomes and treatment response in psychiatric populations, including pharmacological, chronobiological, neurobiofeedback, and psychotherapeutic interventions. I am particularly interested in the application of innovative machine learning procedures for a personalized medicine in psychiatry.

Brenda Penninx, PhD, is professor of psychiatric epidemiology at the department of Psychiatry of Amsterdam UMC (location VUmc) in Amsterdam (https://psychiatryamsterdam.nl). Since 2004 she leads the Netherlands Study of Depression and Anxiety (NESDA: www.nesda.nl), a longitudinal study of the course and consequences of depressive and anxiety disorders. Prof. Penninx is currently also involved in several other (national and EU-funded) mental health cohort and intervention studies. Central themes in her research are understanding psychosocial, somatic and neurobiological risk factors and consequences of depression and anxiety disorders and how to impact on these to improve mental health. Penninx leads a successful research group involving over 30 junior and senior researchers and has widely published (>800 papers, >60,000 citations). Since 2016, she is elected member of the Royal Netherlands Academy of Arts and Sciences, of which she serves currently as Vice-President.